In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. (Q53416070)

14 May 2018

title

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. (English)

1 reference

14 May 2018

1 reference

1 reference

14 May 2018

Katsuaki Suzuki

1 reference

14 May 2018

Yasuhide Iwata

Yasuhide Iwata

1 reference

14 May 2018

Genichi Sugihara

Genichi Sugihara

1 reference

14 May 2018

Shiro Suda

Shiro Suda

1 reference

14 May 2018

Tomoyasu Wakuda

Tomoyasu Wakuda

1 reference

14 May 2018

Takatoshi Ueki

Takatoshi Ueki

1 reference

14 May 2018

Kazuhiko Nakamura

Kazuhiko Nakamura

1 reference

14 May 2018

Kiyokazu Takebayashi

Kiyokazu Takebayashi

1 reference

14 May 2018

Yasuomi Ouchi

Yasuomi Ouchi

1 reference

14 May 2018

Mitsuru Kikuchi

Mitsuru Kikuchi

1 reference

14 May 2018

Etsuji Yoshikawa

Etsuji Yoshikawa

1 reference

14 May 2018

Yujiro Yoshihara

Yujiro Yoshihara

1 reference

14 May 2018

author name string

Masamichi Yokokura

1 reference

14 May 2018

Norio Mori

1 reference

14 May 2018

Shunsuke Yagi

1 reference

14 May 2018

publication date

16 September 2010

1 reference

14 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

14 May 2018

volume

1 reference

14 May 2018

issue

1 reference

14 May 2018

page(s)

343-351

1 reference

14 May 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Role of toll-like receptor signalling in Abeta uptake and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Altered glucose metabolism in the hippocampal head in memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Microglial activation and dopamine terminal loss in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Anti-inflammatory drugs and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis

21 January 2018

1 reference

12 December 2020

Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

1 reference

12 December 2020

Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography

1 reference

12 December 2020

Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

1 reference

12 December 2020

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

1 reference

12 December 2020

10.1007/S00259-010-1612-0

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018